Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Compugen Ltd (NQ: CGEN )

2.119 -0.011 (-0.51%)
Streaming Delayed Price Updated: 12:45 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Compugen Ltd

< Previous 1 2 3 4 5 Next >
Why Shares of Compugen Jumped 9.27% on Tuesday
The stock's rise came after the company announced when third-quarter earnings will be presented. 
Via The Motley Fool
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. 
Via Benzinga
Analyst Ratings for Compugen
Within the last quarter, Compugen (NASDAQ:CGEN) has observed the following analyst ratings: 
Via Benzinga
Compugen: Q2 Earnings Insights
  Compugen (NASDAQ:CGEN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Compugen Q1 Earnings
Compugen (NASDAQ:CGEN) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
5 Top Stocks Cathie Wood Sold This Week
August was not a pleasant month for Cathie Wood and ARKK as the ETF experienced outflows of $803 million, the most since last September. 
Via InvestorPlace
Truist Securities Maintains Buy Rating for Compugen: Here's What You Need To Know
Truist Securities has decided to maintain its Buy rating of Compugen (NASDAQ:CGEN) and lower its price target from $14.00 to $4.00. Shares of Compugen are trading up 2.29% over the last 24 hours, at... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
Cathie Wood Scoops Up Over $20M Worth Of Fate Therapeutics Shares, Dumps More Twitter Stock
Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds... 
Via Benzinga
JMP Securities Maintains Market Outperform Rating for Compugen: Here's What You Need To Know
  JMP Securities has decided to maintain its Market Outperform rating of Compugen (NASDAQ:CGEN) and lower its price target from $8.00 to $4.00. Shares of Compugen are trading up 1.37% over the last 24... 
Via Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in... 
Via Benzinga
Earnings Preview For Compugen
Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Compugen will... 
Via Benzinga
Earnings Outlook For Compugen
Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Compugen will report... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
World Markets News For Friday
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%. 
Via Talk Markets
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
Gold up, Stocks down
The gold market came back to life after a one-day hiatus. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
Inflation inflating
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays. 
Via Talk Markets
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
The Last Day In January
The market is suspicious of the moves up to right matters. 
Via Talk Markets
Drug Troubles
The drug sector has both good news and bad. 
Via Talk Markets
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Wednesday File
It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year. 
Via Talk Markets
Chopped Stocks
The day's theme is sell tech and buy banks. 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.